vaccination failure; sars-cov-2 infection; this is a spontaneous report received from a contactable reporter (physician) from the regulatory authority-web. regulatory number: at-basgages-2022-015095 (ra). a 37 year-old female patient received bnt162b2 (comirnaty), intramuscular, administration date 10jul2021 (lot number: fe6208) as dose 2, single and intramuscular, administration date 29may2021 (lot number: fc0681) as dose 1, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. the following information was reported: drug ineffective (medically significant) with onset 30oct2021, outcome "unknown", described as "vaccination failure"; covid-19 (medically significant) with onset 30oct2021, outcome "unknown", described as "sars-cov-2 infection". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (30oct2021) positive, notes: variant pcr-based: b.1.617.2; variant sequenced: n.a.n501y positive: no. no follow-up attempts are possible. no further information is expected.; sender's comments: linked report(s) : at-pfizer inc-202200283202 same patient/reporter/different dose/events

test date: 20211030; test name: covid-19 pcr test; test result: positive ; comments: variant pcr-based: b.1.617.2 variant sequenced: n.a. n501y positive: no

na

na